False-Negative Results in Lung Cancer Screening-Evidence and Controversies.
Identifying false-negative cases is an important quality metric in lung cancer screening, but it has been infrequently and variably reported in previous studies. Although as a proportion of all screening participants, false-negative cases are uncommon, such cases may constitute a substantial proportion of all lung cancers diagnosed (up to 15%) within a screening program. This article reviews the impact and causes of false-negative lung cancer screening tests, including those related to radiologic evaluation, nodule management protocols, and management decisions made by multidisciplinary teams. Following a review of data from international screening studies, this article discusses the controversies within the screening literature surrounding the definition and classification of a false-negative lung cancer screening test and how data on false-negative rates should be captured and recorded. Challenges, such as avoiding overly cautious surveillance of lung nodules while minimizing overdiagnosis and investigation of indolent or benign lesions, are considered. Finally, the advantages and disadvantages of different approaches to dealing with false-negative results in lung cancer screening are discussed.
['Bartlett|Emily C|EC|', 'Silva|Mario|M|', 'Callister|Matthew E|ME|', 'Devaraj|Anand|A|']
D055088:Early Detection of Cancer D006801:Humans D008168:Lung D008175:Lung Neoplasms D008403:Mass Screening D014057:Tomography, X-Ray Computed
Lung cancer Lung cancer screening Lung nodule Computed tomography False negatives